What is the size of the Adalimumab Biosimilar market in 2023?

The Adalimumab Biosimilar market size is USD 738.3 million in 2023.

What is the projected CAGR at which the Adalimumab Biosimilar market is expected to grow at?

The Adalimumab Biosimilar market is expected to grow at a CAGR of 23.4% (2024-2033).

List the segments encompassed in this report on the Adalimumab Biosimilar market?

Market.US has segmented the Adalimumab Biosimilar market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Product the market has been segmented into Exemptia, Adalirel, Cipleumab, Others. By Distribution Channel the market has been segmented into Hospitals Pharmacies, Retail Pharmacies, Others.

List the key industry players of the Adalimumab Biosimilar market?

Alfred E. Tiefenbacher, Amgen Inc., Boehringer Ingelheim International GmbH, Glenmark, Zydus Group, Torrent Pharmaceuticals Ltd., Emcure Pharmaceuticals Ltd, AET BioTech, Coherus Biosciences, Fujifilm Kyowa Kirin Biologics Co. Ltd.

Which region is more appealing for vendors employed in the Adalimumab Biosimilar market?

North America is expected to account for the highest revenue share of 23.4% and boasting an impressive market value of USD 3.2 billion. Therefore, the Adalimumab Biosimilar industry in North America is expected to garner significant business opportunities over the forecast period.

Global Adalimumab Biosimilar Market Analysis By Product (Exemptia, Adalirel, Cipleumab, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Dec 2023
Report ID: 36720
Number of Pages: 274
Format:

- Alfred E. Tiefenbacher
- Amgen Inc.
- Boehringer Ingelheim International GmbH
- Glenmark
- Zydus Group
- Torrent Pharmaceuticals Ltd.
- Emcure Pharmaceuticals Ltd
- AET BioTech
- Coherus Biosciences
- Fujifilm Kyowa Kirin Biologics Co. Ltd.
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 36720
Published Date Dec 2023
Rating
- ★★★★★
  
  ★★★★★
- (21)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)